Related Experiment Videos
p27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite
Xun Che1, Jinyi Liu, Haishan Huang
1Nelson Institute of Environmental Medicine, New York University, School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.
Abstract:
p27 is a cyclin-dependent kinase (CDK) inhibitor that suppresses a cell's transition from G0 to S phase, therefore acting as a tumor suppressor. Our most recent studies demonstrate that upon arsenite exposure, p27 suppresses Hsp27 and Hsp70 expressions through the JNK2/c-Jun- and HSF-1-dependent pathways, suggesting a novel molecular mechanism underlying the tumor suppressive function of p27 in a CDK-independent manner. We found that p27-deficiency (p27-/-) resulted in the elevation of cyclooxygenase-2 (COX-2) expression at transcriptional level, whereas the introduction of p27 brought back COX-2 expression to a level similar to that of p27+/+ cells, suggesting that p27 exhibits an inhibitory effect on COX-2 expression. Further studies identified that p27 inhibition of COX-2 expression was specifically due to phosphorylation of transcription factor cAMP response element binding (CREB) phosphorylation mediated by p38β and p38δ. These results demonstrate a novel mechanism underlying tumor suppression effect of p27 and will contribute to the understanding of the overall mechanism of p27 tumor suppression in a CDK-independent manner.
Insights
The tumor suppressor p27 inhibits cyclooxygenase-2 (COX-2) expression via p38β/δ-mediated CREB phosphorylation, revealing a novel CDK-independent cancer suppression mechanism.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- p27 is a cyclin-dependent kinase (CDK) inhibitor and tumor suppressor.
- p27 regulates cell cycle G0 to S phase transition.
- Novel CDK-independent functions of p27 are being investigated.
Purpose of the Study:
- To elucidate novel mechanisms of p27 tumor suppression.
- To investigate the role of p27 in regulating cyclooxygenase-2 (COX-2) expression.
- To identify molecular pathways involved in p27's CDK-independent functions.
Main Methods:
- Investigated p27-deficiency (p27-/-) and p27 introduction effects on COX-2 expression.
- Analyzed transcriptional regulation of COX-2.
- Identified key signaling pathways including p38β, p38δ, and CREB phosphorylation.
Main Results:
- p27 deficiency elevates COX-2 expression transcriptionally.
- p27 introduction restores COX-2 expression to normal levels.
- p27 inhibits COX-2 via p38β/δ-mediated phosphorylation of CREB.
Conclusions:
- p27 exhibits a novel tumor suppressive role through CDK-independent inhibition of COX-2.
- The p38β/δ-CREB pathway is critical for p27's regulation of COX-2.
- These findings expand the understanding of p27's multifaceted tumor suppressor functions.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell Specific Gene Expression
Negative Regulator Molecules